Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy in Locally Advanced Cervical Cancer After NACT and Surgery
NCT04733820Phase 3Recruiting
- Sponsor
- Huazhong University of Science and Technology
- Start
- Feb 2021
- Primary completion
- Feb 2028
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, docetaxel, cisplatin, carboplatin in Cervical Cancer (CC), sponsored by Huazhong University of Science and Technology. Started Feb 2021; status: recruiting.
02
Drugs
paclitaxeldocetaxelcisplatincarboplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04733820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04733820.